Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population

Código QR

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population

Julia Berman,1,2,&ast; Victoria Furer,2,3,&ast; Mark Berman,2,3 Ofer Isakov,1,2 Devy Zisman,4,5 Amir Haddad,4 Ori Elkayam2,3 1Department of Medicine ‘T’, Sourasky Medical Center, Tel Aviv, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 3Department of Rheumatolog...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Berman J, Furer V, Berman M, Isakov O, Zisman D, Haddad A, Elkayam O
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	secukinumab ixekizumab arthritis psoriatic duration of therapy antibodies monoclonal humanized psoriasis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c2e06e5f06614c15a2701659f24f682e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical evidence of therapy for genital psoriasis by biologic agents
por: Evgeny V. Sokolovskiy, et al.
Publicado: (2021)

Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Fei Qi, et al.
Publicado: (2021)

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
por: A. A. Barilo, et al.
Publicado: (2019)

Prevalence of Psoriatic Arthritis among Psoriatic Patients in Damietta Governorate
por: Aisha Mohamed, et al.
Publicado: (2019)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: S. V. Smirnova, et al.
Publicado: (2014)

Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
por: D'Angelo S, et al.
Publicado: (2017)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020)

The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: M. V. Smolnikova, et al.
Publicado: (2014)

Editorial: Early Origins of Psoriatic Arthritis
por: David Simon, et al.
Publicado: (2021)

A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report
por: Rowawi R, et al.
Publicado: (2020)

Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population
por: Cassia FF, et al.
Publicado: (2021)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon S, et al.
Publicado: (2017)

The Digital Way to Intercept Psoriatic Arthritis
por: Ivan Giovannini, et al.
Publicado: (2021)

Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
por: Maria-Loukia Koutsompina, et al.
Publicado: (2021)

The metabolomics of psoriatic disease
por: Yan D, et al.
Publicado: (2017)

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
por: Liu L, et al.
Publicado: (2016)

Local effects of adipose tissue in psoriasis and psoriatic arthritis
por: Kruglikov IL, et al.
Publicado: (2017)

Predictive role of serum rheumatoid factor in different disease pattern of psoriasis and psoriatic arthritis
por: Enas Zahran, et al.
Publicado: (2021)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi A, et al.
Publicado: (2019)

Comparison of Behavioral Risk Factors and Cardiometabolic Comorbidities of Psoriatic Arthritis and Psoriasis: A Case–Control Study in Chinese Patients
por: Wang Q, et al.
Publicado: (2021)

The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
por: van Muijen ME, et al.
Publicado: (2020)

Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies
por: Degli Esposti L, et al.
Publicado: (2018)

Secukinumab in the treatment of psoriasis: patient selection and perspectives
por: Yang EJ, et al.
Publicado: (2018)

Role of endothelial cell specific molecule-1 (endocan) and cardiac imaging in early detection of cardiac involvement in psoriatic patients with or without arthritis
por: Salwa M.A. Ibrahim, et al.
Publicado: (2022)

Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)
por: Valdés A,María del Pilar, et al.
Publicado: (2006)

Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
por: Fusun Gediz, et al.
Publicado: (2021)

Quality of life in patients with psoriatic arthritis
por: Kseniya Mikhailovna Koreshkova, et al.
Publicado: (2021)

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
por: Zarema R. Khismatullina, et al.
Publicado: (2021)

ASSOCIATION BETWEEN POLYMORPHIC MARKERS OF THE IL4 (с-590Т) AND IL10 (с-597А) GENES AND PSORIATIC ARTHRITIS
por: M. V. Smolnikova, et al.
Publicado: (2012)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
por: Ly K, et al.
Publicado: (2019)

Psoriasis: Targets and Therapy
Publicado: (2012)

Generalized tinea versicolor following initiation of ixekizumab therapy
por: Haroon Sayed Alam, BS, et al.
Publicado: (2021)

Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China
por: Miao Chen, et al.
Publicado: (2021)

Frequency of Health Care Resource Utilization and Direct Medical Costs Associated with Psoriatic Arthritis in a Rheumatic Care Center in Colombia
por: Santos-Moreno P, et al.
Publicado: (2021)

Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series
por: Brown AN
Publicado: (2016)

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti MS, et al.
Publicado: (2020)

Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
por: M. V. Smolnikova, et al.
Publicado: (2020)

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis
por: Sueli Carneiro, et al.
Publicado: (2021)

Genetic markers for psoriatic arthritis in patients with psoriasis. Part I: non-HLA genes
por: Alexey A. Kubanov, et al.
Publicado: (2021)